Viemed Healthcare Q2 2022 core revenue $33.1M record, up 26% YoY; adjusted EBITDA $6.5M

VIEMED HEALTHCARE, INC.

2022-Q2 EPS reported $0.07 revenue$65,565,000

Q2 core net revenues $33.1M (record); total revenues including COVID-19 services $33.3M.
Adjusted EBITDA of $6.5M for Q2 2022 and $13.7M for six months ended June 30, 2022.
Ventilator patient count 8,837, up 9% YoY; highest quarterly growth since Q2 2019.
Repurchased 1,350,567 shares at avg $5.18 per share, total cost $7.0M.
Medicare overpayment exposure reduced to $1.1M after reconsideration; appeals filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.